Prospective associations of circulating thrombospondin-2 level with heart failure hospitalization, left ventricular remodeling and diastolic function in type 2 diabetes

Autor: C H, Lee, M Z, Wu, Dtw, Lui, Chy, Fong, Q W, Ren, S Y, Yu, Mma, Yuen, W S, Chow, J Y, Huang, A, Xu, K H, Yiu, Ksl, Lam

Publikováno v: Cardiovascular Diabetology. 21

Background Circulating thrombospondin-2 (TSP2) levels were associated with the development of heart failure (HF) in recent studies. However, these studies included only a minority of patients with type 2 diabetes, which is associated with an increase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbe6cf5e571b064d2aac958c5b6b2b4c
https://doi.org/10.1186/s12933-022-01646-x

OP19 CIRCULATING ADIPOCYTE FATTY ACID BINDING PROTEIN LEVELS PREDICT THE PROGRESSION OF NEPHROPATHY IN TYPE 2 DIABETES MELLITUS

Autor: Chp Lee, E.Y.L. Hui, Mma Yuen, Wing Sun Chow, Karen Siu-Ling Lam, Carol H.Y. Fong, C.Y. Yeung, YC Woo, Aimin Xu

Publikováno v: Diabetes Research and Clinical Practice. 106:S10

interaction. Lee WJ, Huey-Herng Sheu W, Liu SH, Yi YC, Chen WC, Lin SY, Liang KW, Shen CC, Yeh HY, Lin LY, Tsai YC, Tien HR, Lee MR, Yang TJ, Sheu ML. Free Radic Biol Med. 2014 Jul 8; 74C: 294–306. [2] Advanced glycation end product Ne-carboxymethy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7523e94c498ee742f381c7ef88522251
https://doi.org/10.1016/s0168-8227(14)70225-6

Health Complications of Obesity: 224 Obesity-Associated Comorbidities from a Mechanistic Perspective.

Autor: Yuen MMA; Department of Medicine, Obesity, Metabolism and Nutrition Institute, Massachusetts General Hospital; University of Hong Kong, 102 Pokfulam Road, Pok Fu Lam, Hong Kong. Electronic address: micheleyuen@gmail.com.

Publikováno v: Gastroenterology clinics of North America [Gastroenterol Clin North Am] 2023 Jun; Vol. 52 (2), pp. 363-380.

Different glycaemia-related risk factors for incident Alzheimer's disease in men and women with type 2 diabetes-A sex-specific analysis of the Hong Kong diabetes database.

Autor: Lee CH; State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China.; Department of Medicine, University of Hong Kong, Hong Kong, China., Lui DTW; Department of Medicine, University of Hong Kong, Hong Kong, China., Cheung CYY; Department of Medicine, University of Hong Kong, Hong Kong, China., Woo YC; Department of Medicine, University of Hong Kong, Hong Kong, China., Fong CHY; Department of Medicine, University of Hong Kong, Hong Kong, China., Yuen MMA; Department of Medicine, University of Hong Kong, Hong Kong, China., Shea YF; Department of Medicine, University of Hong Kong, Hong Kong, China., Siu DCW; Department of Medicine, University of Hong Kong, Hong Kong, China., Chan KH; Department of Medicine, University of Hong Kong, Hong Kong, China., Chow WS; Department of Medicine, University of Hong Kong, Hong Kong, China., Lam KSL; State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China.; Department of Medicine, University of Hong Kong, Hong Kong, China.

Publikováno v: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2021 Sep; Vol. 37 (6), pp. e3401. Date of Electronic Publication: 2020 Sep 11.

Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes.

Autor: Ng KKK; Department of Medicine, The University of Hong Kong, Hong Kong, Cheung CYY; Department of Medicine, The University of Hong Kong, Hong Kong; State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, Lee CH; Department of Medicine, The University of Hong Kong, Hong Kong, Fong CHY; Department of Medicine, The University of Hong Kong, Hong Kong, Kwok KHM; Department of Medicine, The University of Hong Kong, Hong Kong, Li KKW; Department of Ophthalmology, United Christian Hospital, Hong Kong, Gangwani RA; Department of Ophthalmology, The University of Hong Kong, Hong Kong, Wong IYH; Department of Medicine, The University of Hong Kong, Hong Kong, Woo YC; Department of Medicine, The University of Hong Kong, Hong Kong, Chow WS; Department of Medicine, The University of Hong Kong, Hong Kong, Yuen MMA; Department of Medicine, The University of Hong Kong, Hong Kong, Wong RLC; Department of Medicine, The University of Hong Kong, Hong Kong, Xu A; Department of Medicine, The University of Hong Kong, Hong Kong; State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong; Research Center of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong, Hong Kong, Wong DSH; Department of Ophthalmology, The University of Hong Kong, Hong Kong, Sham PC; Department of Psychiatry, The University of Hong Kong, Hong Kong, Lam KSL; Department of Medicine, The University of Hong Kong, Hong Kong; State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong; Research Center of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong, Hong Kong

Publikováno v: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2020 Aug 03; Vol. 61 (10), pp. 7.